Ando, F.; Matsuda, A.; Miyamoto, Y.; Sunakawa, Y.; Asatsuma-Okumura, T.; Iwai, Y.; Yoshida, H.
Efficacy of Adding Immune Checkpoint Inhibitors to Chemotherapy Plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials. Cancers 2025, 17, 2538.
https://doi.org/10.3390/cancers17152538
AMA Style
Ando F, Matsuda A, Miyamoto Y, Sunakawa Y, Asatsuma-Okumura T, Iwai Y, Yoshida H.
Efficacy of Adding Immune Checkpoint Inhibitors to Chemotherapy Plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials. Cancers. 2025; 17(15):2538.
https://doi.org/10.3390/cancers17152538
Chicago/Turabian Style
Ando, Fumihiko, Akihisa Matsuda, Yuji Miyamoto, Yu Sunakawa, Tomoko Asatsuma-Okumura, Yoshiko Iwai, and Hiroshi Yoshida.
2025. "Efficacy of Adding Immune Checkpoint Inhibitors to Chemotherapy Plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials" Cancers 17, no. 15: 2538.
https://doi.org/10.3390/cancers17152538
APA Style
Ando, F., Matsuda, A., Miyamoto, Y., Sunakawa, Y., Asatsuma-Okumura, T., Iwai, Y., & Yoshida, H.
(2025). Efficacy of Adding Immune Checkpoint Inhibitors to Chemotherapy Plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials. Cancers, 17(15), 2538.
https://doi.org/10.3390/cancers17152538
